Citigroup
GHDX

Citigroup’s Genomic Health, Inc. GHDX Stock Holding History

Citigroup’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-3,000
Closed -$92K – 7234
2013
Q3 		$92K Hold
3,000
– – ﹤0.01% 4800
2013
Q2 		$95K Buy
+3,000
New +$98.5K ﹤0.01% 4903

Citigroup's GHDX Position: Q4 2019 in Review

Citigroup sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 374,704 shares — an estimated $25.4M sold.

Citigroup first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $25.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Citigroup reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Citigroup sold 374,704 Genomic Health, Inc. shares in Q4 2019, an estimated $25.4M.
  • Citigroup first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
  • Citigroup's Genomic Health, Inc. position peaked at $25.4M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Citigroup's 13F filing for Q4 2019, filed 12 Feb 2020.